The UAE Country of Honor at Thessaloniki International Fair TIF 86: Minister of Economy Heads UAE’s Delegation to Greece with Extensive Government & Private-Sector Participation

Abu Dhabi – 07/09/2022,
- Picture is available at AP Images (http://www.apimages.com) -
The United Arab Emirates (UAE) will participate — with a high-ranking delegation headed by the UAE Minister of Economy, H.E. Abdulla Bin Touq Al Marri — in the Thessaloniki International Fair TIF 86, which will be held in Greece from 10 to 18 September 2022.
The UAE will serve as the Country of Honor at the 86th Thessaloniki International Fair (TIF) in Greece, participating with a prominent delegation that comprises 60 government and private-sector entities.
The delegation will showcase the country’s important economic developments, the latest UAE technology-related products, and the nation’s new economic sectors.
The UAE’s participation in TIF 86 comes in the context of the nation’s pursuit of attracting USD 150 billion in inward foreign investment over the next 9 years to become one of the top 10 global investment destinations — particularly in the New Economy sectors — by 2030.
The UAE’s participation in TIF 86 aims to boost cooperation with the business communities in Greece, the Balkans, and European markets to give momentum to economic development & mutual investments in the UAE and these countries. The UAE’s participation is set to make a lasting impression due to the strength of its delegation
- The UAE aims to create a successful knowledge-based economy and to create a world-class healthcare system.
- UAE is investing heavily in creating a world-leading regulatory framework for IT / AI ventures, providing infrastructure to build the best possible tech-investment ecosystem
- The UAE’s pharmaceutical market presents significant growth opportunities for multinational drug makers.
- The UAE Government is focused on more than doubling the contribution of industrial manufacturing to the UAE’s GDP to 25 percent.
Long version of this press release can be found at:
https://www.presseportal.de/nr/165110?langid=2
Contact:
Rana Elshorbagy
rana.elshorbagy@strategic.ae
Bilder

Om news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Følg pressemeldinger fra news aktuell GmbH
Registrer deg med din e-postadresse under for å få de nyeste sakene fra news aktuell GmbH på e-post fortløpende. Du kan melde deg av når som helst.
Siste pressemeldinger fra news aktuell GmbH
Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity8.1.2026 09:00:00 CET | Press release
Tübingen, Germany, January 8, 2026 Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across multiple preclinical hearing loss models, including drug-induced ototoxicity. The PROHEAR Study is a double-blind, randomized, placebo-controlled, split-body, multicenter Phase 2 trial. It enrolled young male patients with metastatic testicular cancer who are scheduled to receive cisplatin-based chemotherapy. While cisplatin is a highly effective chemotherapeutic agent, cumulative doses of ≥300 mg/m² lead to clinically meaningful, permanent hearing loss in the majority of patients. Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized
Dr. Stefanie Kesting appointed as CEO of Thyssengas7.1.2026 14:06:26 CET | Press release
Dortmund, 06.01.2026 As of January 1, 2026, Dr. Stefanie Kesting has been appointed as the new Chief Executive Officer (CEO) of Thyssengas GmbH. She succeeds Dr. Thomas Gößmann, who will retire at the end of February 2026 after nearly nine years at the helm of the company. The leadership transition was announced in autumn 2025.
30 Years of European Spas: Nature, Natural Remedies and Climate Health as Europe’s Unique Strength7.1.2026 08:59:31 CET | Press release
To mark its 30th anniversary, the European Spas Association (ESPA) has released a special commemorative publication highlighting the strategic role of Europe’s medical spas and climate-health resorts in an era defined by prevention, longevity and sustainable wellbeing.
Forum for a self-reliant and self-determined Europe - the "Sovereign Europe Forum"23.12.2025 08:40:47 CET | Press release
Entrepreneurs, top managers and leaders from United Europe e.V. and European Forum Alpbach (EFA) are founding the Sovereign Europe Forum i.G.
Digital Subsidiary of Austrian State Printing Company Wins Infrastructure Tender for German EU Digital Identity Wallet22.12.2025 15:12:30 CET | Press release
youniqx Identity, a digital subsidiary of the Austrian State Printing Company (OSD), has won a Europe-wide tender, together with partner companies, for the infrastructure of the German EU Digital Identity Wallet (EUDI-Wallet). EU member states are required by EU regulations to provide a national version of an EU-wide valid EUDI-Wallet by the end of 2026. Citizens will be able to use the EUDI-Wallet to prove their personal identity throughout the EU
I vårt presserom finner du alle våre siste pressemeldinger, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.
Besøk vårt presserom
